These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 32461211)

  • 41. Relationship Between Daytime Versus Nighttime Continuous Glucose Monitoring Metrics with A1C in Adults with Type 1 Diabetes.
    Shah VN; Akturk HK; Vigers T; Pyle L; Oliver N; Klonoff DC
    Diabetes Technol Ther; 2023 Jan; 25(1):62-68. PubMed ID: 36306519
    [No Abstract]   [Full Text] [Related]  

  • 42. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring.
    Bergenstal RM; Beck RW; Close KL; Grunberger G; Sacks DB; Kowalski A; Brown AS; Heinemann L; Aleppo G; Ryan DB; Riddlesworth TD; Cefalu WT
    Diabetes Care; 2018 Nov; 41(11):2275-2280. PubMed ID: 30224348
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lag Time Remains with Newer Real-Time Continuous Glucose Monitoring Technology During Aerobic Exercise in Adults Living with Type 1 Diabetes.
    Zaharieva DP; Turksoy K; McGaugh SM; Pooni R; Vienneau T; Ly T; Riddell MC
    Diabetes Technol Ther; 2019 Jun; 21(6):313-321. PubMed ID: 31059282
    [No Abstract]   [Full Text] [Related]  

  • 44. Continuous Glucose Monitoring in Pregnancy: Importance of Analyzing Temporal Profiles to Understand Clinical Outcomes.
    Scott EM; Feig DS; Murphy HR; Law GR;
    Diabetes Care; 2020 Jun; 43(6):1178-1184. PubMed ID: 32209645
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glucose Patterns in Very Old Adults: A Pilot Study in a Community-Based Population.
    Selvin E; Wang D; Tang O; Minotti M; Echouffo-Tcheugui JB; Coresh J
    Diabetes Technol Ther; 2021 Nov; 23(11):737-744. PubMed ID: 34191599
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of 6 Months of Flash Glucose Monitoring in Youth With Type 1 Diabetes and High-Risk Glycemic Control: A Randomized Controlled Trial.
    Boucher SE; Gray AR; Wiltshire EJ; de Bock MI; Galland BC; Tomlinson PA; Rayns JA; MacKenzie KE; Chan H; Rose S; Wheeler BJ
    Diabetes Care; 2020 Oct; 43(10):2388-2395. PubMed ID: 32788281
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Switching from Intermittently Scanned Continuous Glucose Monitoring to Real-Time Continuous Glucose Monitoring with a Predictive Urgent Low Soon Alert Reduces Exposure to Hypoglycemia.
    Preechasuk L; Avari P; Oliver N; Reddy M
    Diabetes Technol Ther; 2024 Jul; 26(7):498-502. PubMed ID: 38315504
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Glucose Management Indicator: Time to Change Course?
    Selvin E
    Diabetes Care; 2024 Jun; 47(6):906-914. PubMed ID: 38295402
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Usefulness of CGM-Derived Metric, the Glucose Management Indicator, to Assess Glycemic Control in Non-White Individuals With Diabetes.
    Toschi E; Michals A; Adam A; Davis D; Atakov-Castillo A; Slyne C; Munshi M
    Diabetes Care; 2021 Dec; 44(12):2787-2789. PubMed ID: 34635503
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dynamics of Hemoglobin A1c, Body Mass Index, and Rates of Severe Hypoglycemia in 4434 Adults with Type 1 or Type 2 Diabetes After Initiation of Continuous Glucose Monitoring.
    Lanzinger S; Best F; Bergmann T; Laimer M; Lipovsky B; Danne T; Zimny S; Bramlage P; Meyhöfer S; Holl RW
    Diabetes Technol Ther; 2022 Oct; 24(10):763-769. PubMed ID: 35653726
    [No Abstract]   [Full Text] [Related]  

  • 51. Identification of clinically relevant dysglycemia phenotypes based on continuous glucose monitoring data from youth with type 1 diabetes and elevated hemoglobin A1c.
    Kahkoska AR; Adair LA; Aiello AE; Burger KS; Buse JB; Crandell J; Maahs DM; Nguyen CT; Kosorok MR; Mayer-Davis EJ
    Pediatr Diabetes; 2019 Aug; 20(5):556-566. PubMed ID: 30972889
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation Between the Glycemia Risk Index and Longitudinal Hemoglobin A1c in Children and Young Adults With Type 1 Diabetes.
    Panfil K; Redel JM; Vandervelden CA; Lockee B; Kahkoska AR; Tallon EM; Williams DD; Clements MA
    J Diabetes Sci Technol; 2024 Jul; 18(4):771-778. PubMed ID: 38715286
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study.
    Shah VN; DuBose SN; Li Z; Beck RW; Peters AL; Weinstock RS; Kruger D; Tansey M; Sparling D; Woerner S; Vendrame F; Bergenstal R; Tamborlane WV; Watson SE; Sherr J
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4356-4364. PubMed ID: 31127824
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improved CGM Glucometrics and More Visits for Pediatric Type 1 Diabetes Using Telemedicine During 1 Year of COVID-19.
    Kaushal T; Tinsley LJ; Volkening LK; Turcotte C; Laffel LM
    J Clin Endocrinol Metab; 2022 Sep; 107(10):e4197-e4202. PubMed ID: 35948357
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A cognitive behavioral therapy intervention to reduce fear of hypoglycemia in young adults with type 1 diabetes (FREE): study protocol for a randomized controlled trial.
    Martyn-Nemeth P; Duffecy J; Quinn L; Park C; Mihailescu D; Penckofer S
    Trials; 2019 Dec; 20(1):796. PubMed ID: 31888691
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of Factory-Calibrated Real-time Continuous Glucose Monitoring Improves Time in Target and HbA
    Thabit H; Prabhu JN; Mubita W; Fullwood C; Azmi S; Urwin A; Doughty I; Leelarathna L
    Diabetes Care; 2020 Oct; 43(10):2537-2543. PubMed ID: 32723843
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of CGM-Derived Measures of Glycemic Variability Between Pancreatogenic Diabetes and Type 2 Diabetes Mellitus.
    Shivaprasad C; Aiswarya Y; Kejal S; Sridevi A; Anupam B; Ramdas B; Gautham K; Aarudhra P
    J Diabetes Sci Technol; 2021 Jan; 15(1):134-140. PubMed ID: 31282179
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of Composite Glycemic Indices: A Comparison of the Comprehensive Glucose Pentagon Across Diabetes Types and HbA1c Levels.
    Rama Chandran S; A Vigersky R; Thomas A; Lim LL; Ratnasingam J; Tan A; S L Gardner D
    Diabetes Technol Ther; 2020 Feb; 22(2):103-111. PubMed ID: 31502876
    [No Abstract]   [Full Text] [Related]  

  • 60. COVID-19 Pandemic and Pediatric Type 1 Diabetes: No Significant Change in Glycemic Control During The Pandemic Lockdown of 2020.
    Nwosu BU; Al-Halbouni L; Parajuli S; Jasmin G; Zitek-Morrison E; Barton BA
    Front Endocrinol (Lausanne); 2021; 12():703905. PubMed ID: 34447352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.